tapia < target < targeted

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by target

Number of relevant bibliographic references: 49.
[0-20] [0 - 20][0 - 49][20-40]

Ident.	Authors (with country if any)	Title
000006 (2020)	John Billington [Belgique] ; Isabelle Deschamps [France] ; Stanley C. Erck [États-Unis] ; Julie L. Gerberding [États-Unis] ; Emmanuel Hanon [Belgique] ; Sabrina Ivol [Pays-Bas] ; John W. Shiver [France] ; Julia A. Spencer [États-Unis] ; Johan Van Hoof [Pays-Bas]	Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks.
000007 (2020)	Adrian S Ftoiu ; Victor Tomulescu ; Marcel Tan U ; Cristian Gheorghe ; Eugen Dumitru ; Bogdan Mateescu ; Lucian Negreanu ; Mariana Jinga ; Andrada Seicean ; Mihai Ciocîrlan ; Vasile Drug ; Mircea M Nuc ; R Zvan Popescu ; C Lin Tiu ; Vasile Bin In An ; Valentin Calu ; Valeriu Urlin ; Florin Turcu ; Florin Zaharie ; Dan Ulmeanu ; Dan Brebu ; Alexandru Nicolau ; Mircea Li Escu ; Bogdan Diaconescu ; Ciprian Du ; C T Lin Cop Escu	SRED-ARCE Recommendations for Minimally Invasive Interventions During the COVID-19 Pandemic in Romania.
000019 (2020)	Annie Ladoux [France] ; Stéphane Azoulay [France] ; Christian Dani [France]	[SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
000056 (2020)	Joachim Alexandre [France] ; Jean-Luc Cracowski [France] ; Vincent Richard [France] ; Béatrice Bouhanick [France]	Drugs acting on renin angiotensin system and use in ill patients with COVID-19.
000135 (2020)	Emmanuel Pardo [France]	[Nutritional support for critically ill patients suffering from SARS-CoV-2 infection].
000268 (2020)	Zhenlin Li [France] ; Denise Paulin [France] ; Patrick Lacolley [France] ; Dario Coletti [France, Italie] ; Onnik Agbulut [France]	Vimentin as a target for the treatment of COVID-19.
000284 (2020)	Lionel Roques [France] ; Etienne K. Klein [France] ; Julien Papaïx [France] ; Antoine Sar [Suisse] ; Samuel Soubeyrand [France]	Using Early Data to Estimate the Actual Infection Fatality Ratio from COVID-19 in France.
000367 (2020)	Agnès Ribes [France] ; Fanny Vardon-Bounes [France] ; Vincent Mémier [France] ; Michael Poette [France] ; Jonathan Au-Duong [France] ; Cédric Garcia [France] ; Vincent Minville [France] ; Pierre Sié [France] ; Alessandra Bura-Rivière [France] ; Sophie Voisin [France] ; Bernard Payrastre [France]	Thromboembolic events and Covid-19.
000379 (2020)	Stéphanie Pons [France] ; Sofiane Fodil [France] ; Elie Azoulay [France] ; Lara Zafrani [France]	The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.
000470 (2020)	Frédéric Jiguet [France]	The Fox and the Crow. A need to update pest control strategies.
000472 (2020)	Marc Arbyn [Belgique] ; Murat Gultekin [Turquie] ; Philippe Morice [France] ; Pekka Nieminen [Finlande] ; Maggie Cruickshank [Royaume-Uni] ; Philip Poortmans [Belgique] ; Daniel Kelly [Royaume-Uni] ; Mario Poljak [Slovénie] ; Christine Bergeron [France] ; David Ritchie [Belgique] ; Dietmar Schmidt [Allemagne] ; Maria Kyrgiou [Royaume-Uni] ; Ann Van Den Bruel [Belgique] ; Laia Bruni [Espagne] ; Partha Basu [France] ; Freddie Bray [France] ; Elisabete Weiderpass [France]	The European response to the WHO call to eliminate cervical cancer as a public health problem.
000535 (2020)	Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France]	Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
000536 (2020)	Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France]	Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
000561 (2020)	Natesh Singh [France] ; Etienne Decroly [France] ; Abdel-Majid Khatib [France] ; Bruno O. Villoutreix [France]	Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages.
000562 (2020)	Manish Sarkar [Inde] ; Soham Saha [France]	Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies.
000602 (2020)	Neal G. Ravindra [États-Unis] ; Mia Madel Alfajaro [États-Unis] ; Victor Gasque [États-Unis, France] ; Jin Wei [États-Unis] ; Renata B. Filler [États-Unis] ; Nicholas C. Huston [États-Unis] ; Han Wan [États-Unis] ; Klara Szigeti-Buck [États-Unis] ; Bao Wang [États-Unis] ; Ruth R. Montgomery [États-Unis] ; Stephanie C. Eisenbarth [États-Unis] ; Adam Williams [États-Unis] ; Anna Marie Pyle [États-Unis] ; Akiko Iwasaki [États-Unis] ; Tamas L. Horvath [États-Unis] ; Ellen F. Foxman [États-Unis] ; David Van Dijk [États-Unis] ; Craig B. Wilen [États-Unis]	Single-cell longitudinal analysis of SARS-CoV-2 infection in human bronchial epithelial cells.
000622 (2020)	Sébastien Nisole [France] ; Aure Saulnier ; Anne Gatignol [Canada]	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?
000634 (2020)	Ferdinando D'Amico [Italie, France] ; Patrick Netter [France] ; Cedric Baumann [France] ; Muriel Veltin [France] ; Camille Zallot [France] ; Isabelle Aimone-Gastin [France] ; Silvio Danese [Italie] ; Laurent Peyrin-Biroulet [France]	Setting up a Virtual Calprotectin Clinic in Inflammatory Bowel Diseases: Literature Review and Nancy Experience.
000700 (2020)	Daria Sicari [France, Italie] ; Aristotelis Chatziioannou [Grèce] ; Theodoros Koutsandreas [Grèce] ; Roberto Sitia [Italie] ; Eric Chevet [France, Italie]	Role of the early secretory pathway in SARS-CoV-2 infection.
000774 (2020)	Ashleigh Shannon [France] ; Nhung Thi-Tuyet Le [France] ; Barbara Selisko [France] ; Cecilia Eydoux [France] ; Karine Alvarez [France] ; Jean-Claude Guillemot [France] ; Etienne Decroly [France] ; Olve Peersen [France] ; Francois Ferron [France] ; Bruno Canard [France]	Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
000803 (2020)	Minh Patrick Lê [France] ; Nathan Peiffer-Smadja [France] ; Jeremie Guedj [France] ; Nadège Néant [France] ; France Mentré [France] ; Florence Ader [France] ; Yazdan Yazdanpanah [France] ; Gilles Peytavin [France]	Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "target" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "target" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    target
}}

---

This area was generated with Dilib version V0.6.37. Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021